Phoenix Bio

LATEST ACADEMIC CONFERENCE PRESENTATIONS

LATEST ACADEMIC CONFERENCE PRESENTATIONS

Result from Studies using PXB-Mouse and PXB-cells being presented at 2017 International HBV Meeting (Including additional presentation)

September 13, 2017

There were  oral  presentation and poster presentations on the use of the PXB-Mouse and PXB-cells at 2017 International HBV Meeting held in Washington, DC from September 3rd to 7th (Including additional presentations).

Oral Presentation

O-97

Title : Acute HBV infection in humanized chimeric mice has multiphasic viral kinetics

Presenter : Dr. Susan Uprichard (Loyola University Medical Center)

Poster Presentations

P-57

Title : Exploring the multiphasic viral kinetics of acute hepatitis B virus infection in humanized chimeric mice using an agent-based modeling approach

Presenter : Dr. Atesmachew Hailegiorgis (Loyola University)

P-130

Title : A Comparison of Viral Suppression by Anti-HDV and Anti-HBV RNA Interference Approaches in a HBV/HDV cDNA-uPA/SCID Chimeric Mouse Model

Presenter : Dr. Xin Ye (Arbutus Biopharma Corp.)

P-133

Title : Novel anti-hepatitis B virus compounds with potently decreasing viral DNA and HBsAg

Presenter : Yoshiko Fukuda (FUJIFILM Corporation)

P-150

Title : GalXC technology enables potent and durable RNAi-mediated inhibition of hepatitis B virus in preclinical models

Presenter : Martin Koser (Dicerna Pharmaceuticals)

C-221

Title : Combinational treatment of CDM/CDMi and entecavir for efficient suppression of cccDNA

Presenter : Dr. Yutaka Furutani (RIKEN CLST)

C-256

Title : Transmission of HBV mediated by extracellular vesicles

Presenter : Dr. Takahiro Sanada (Tokyo Metropolitan Institute of Medical Science)